Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

By David A. Garcia, T. Baglin, J. Weitz, M. Samama. Chest, 2012

827 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/8e8065f83a24d2eea5293d19100dcbb171e3b671

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Internal Medicine

G. Agnelli

Citations in the corpus

Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies (2018, background): “Furthermore, various anticoagulants have been shown to prevent the initiation as well as progression of coagulation and fibrin-clot formation/ propagation [237, 247, 248].”
2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014, background): “Garcia 2012 (167) 22315264 Pharmacology of approved parenteral anticoagulants including indirect anticoagulants”
[2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism]. (2014, neutral): “Accumulation also occurs in patients with moderate renal insufficiency (clearance 30–50 mL/min) and, therefore, the dose should be reduced by 50% in these patients.(283)”
2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014, background): “LMWHs are readily absorbed after subcutaneous administration and have less platelet activation.(323) The anticoagulant activity of LMWH does not require routine monitoring.”
ESC Guidelines on the diagnosis and management of acute pulmonary embolism (2014, background): “Accumulation also occurs in patients with moderate renal insufficiency (clearance 30–50 mL/min) and, therefore, the dose should be reduced by 50% in these patients.(283)”
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Fourth Edition) (2018, background): “Finally, following administration of heparin for more than 5 days, there is a subset of patients who will develop a decrease in the platelet count.(76)”